Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reyes-Parada

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neuropharmacology|July 31, 1999
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of actionC Scorza, R Silveira, D E Nichols, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1995
Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepironeJ M Monti, H Jantos, R Silveira, et al.
Life Sciences|January 1, 1994
4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrateM Reyes-Parada, M C Scorza, R Silveira, et al.
Psychopharmacology|June 1, 1994
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the ratJ M Monti, H Jantos, R Silveira, et al.
Journal of Neurochemistry|October 2, 2002
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitroM Gobbi, M Moia, L Pirona, et al.
Life Sciences|February 24, 2001
ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonistC Acuña-Castillo, C Scorza, M Reyes-Parada, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 1998
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in ratsP Lagos, C Scorza, J M Monti, et al.
Biochemical Pharmacology|December 11, 1997
Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationshipsM C Scorza, C Carrau, R Silveira, et al.
Biochemical Pharmacology|April 20, 1994
Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivativesM Reyes-Parada, M C Scorza, R Silveira, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2012
Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanismC Rozas, S Loyola, G Ugarte, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neuropharmacology|July 31, 1999
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of actionC Scorza, R Silveira, D E Nichols, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1995
Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepironeJ M Monti, H Jantos, R Silveira, et al.
Life Sciences|January 1, 1994
4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrateM Reyes-Parada, M C Scorza, R Silveira, et al.
Psychopharmacology|June 1, 1994
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the ratJ M Monti, H Jantos, R Silveira, et al.
Journal of Neurochemistry|October 2, 2002
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitroM Gobbi, M Moia, L Pirona, et al.
Life Sciences|February 24, 2001
ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonistC Acuña-Castillo, C Scorza, M Reyes-Parada, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 1998
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in ratsP Lagos, C Scorza, J M Monti, et al.
Biochemical Pharmacology|December 11, 1997
Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationshipsM C Scorza, C Carrau, R Silveira, et al.
Biochemical Pharmacology|April 20, 1994
Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivativesM Reyes-Parada, M C Scorza, R Silveira, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2012
Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanismC Rozas, S Loyola, G Ugarte, et al.
Pageof 2